奧洛茲美醫療 HALO 深 滬
等待開盤 09-23 09:30:00 美东时间
115.13
+3.680
+3.30%
華盛通- 最 高115.18
- 今 開111.50
- 成交量 415.15万股
- 最 低 110.95
- 昨 收 111.45
- 總市值 1306.70万
- 52周最高 115.18
- 市盈率 靜 45.02
- 換手率 3657.81%
- 52周最低 61.225
- 委 比 -45.31%
- 總股本 0.00亿
- 歷史最高 115.18
- 量 比 1.17
- 振 幅 3.80%
- 歷史最低 3.86
- 每 手 1
- 風險率 13.07%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Halozyme announces $1.05B convertible notes offering
An update from Halozyme ( ($HALO) ) is now available. On September 16, 2026, Ha...
09-17 05:00
Halozyme Therapeutics Announces Proposed $1.05B Convertible Senior Notes Offering Due 2033
Halozyme Therapeutics, Inc. (NASDAQ:HALO) ("Halozyme" or the "Company"), today announced that it intends to offer, subject to market conditions and other factors, $1.05 billion aggregate principal amount of convertible senior notes due 2033 (the "Convertible Notes"). The Company also expects to gran...
09-17 04:33
美股大行评级 | 最高735美元！戴尔科技绩后获11家大行上调目标价；MongoDB绩后分歧大，9家上调；4家下调；派拓网络、GitLab、美敦力获多家大行上调目标价
今日重点评级关注：Tigress Financial：维持Liftoff Mobile"买入"评级，目标价从39美元升至41美元；奥本海默：维持SpaceX"跑赢大市"评级，目标价从250美元升至280美元
09-03 13:50
HC Wainwright & Co. Reiterates Buy on Halozyme Therapeutics, Maintains $115 Price Target
HC Wainwright & Co. analyst Mitchell S. Kapoor reiterates Halozyme Therapeutics (NASDAQ:HALO) with a Buy and maintains $115 price target.
09-03 01:22
美股盘后 | 诺福克南方上升3.08%，Keysight Technologies Inc上升2.98%
诺福克南方上升3.08%；Keysight Technologies Inc上升2.98%；洛斯公司小升1.93%
08-19 06:10
Halozyme Appoints Dannielle Appelhans to its Board of Directors
SAN DIEGO, Aug. 18, 2026 /PRNewswire/ -- Halozyme Therapeutics, Inc. (Nasdaq: HALO) ("Halozyme") today announced the election of Dannielle Appelhans to its Board of Directors. Ms. Appelhans ...
08-19 04:01
Top 3 Health Care Stocks That May Implode In August
As of Aug. 12, 2026, three stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions. The RSI is a momentum indicator, which compares a stock’s strength on days when prices go up to its strength on days when prices ...
08-12 20:58
美股大行评级 | 花旗下调美光科技目标价从1400美元降至1150美元；爱彼迎、Datadog、Cloudflare、Etsy、Natera、拉夫劳伦获多家大行上调目标价
今日重点评级关注：康托·菲茨杰拉德：维持InflaRx"超配"评级，目标价从4美元升至6美元；RBC Capital：维持Nuvation Bio"跑赢大市"评级，目标价从19美元升至20美元
08-10 19:24
